C63359Level 3

Regimen Used to Treat Small Cell Lung Carcinoma

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** Any regimen that can be used for the treatment of small cell lung carcinoma.

GET/api/v1/systems/nci_thesaurus/nodes/C63359

Official DownloadCC BY 4.0Source

Hierarchy Explorer

Hierarchy ExplorerChevron to expand - click title to open

C10278Doxorubicin/Etoposide/Methotrexate Regimen

C11934IC Regimen

C156250Carboplatin/Topotecan Regimen

C161941CCV Alternating with AV Regimen

C161951CMC Alternating with VAP Regimen

C161972ICE-V Regimen

C162003CAV Alternating with EP Regimen

C190530Lurbinectedin Regimen

C210808Tarlatamab Regimen

C222486Atezolizumab/Lurbinectedin Regimen

C222487Atezolizumab and Recombinant Human Hyaluronidase/Lurbinectedin Regimen

C222804Atezolizumab/Carboplatin/Etoposide Followed by Atezolizumab/Lurbinectedin Regimen

C63384PET Regimen

C63386Cyclophosphamide/Etoposide/Vincristine Regimen

C63763TEC Regimen

C64844EVAC Regimen

C9531Lomustine/Methotrexate/Procarbazine Regimen

C9543Cyclophosphamide/Lomustine/Vincristine Regimen

C9588VOCA Regimen

C9610CMC Regimen

C9700Cyclophosphamide/Etoposide/Methotrexate/Vincristine Regimen

C9711Cyclophosphamide/Etoposide/Lomustine/Vincristine Regimen

C9714COPE Regimen

Cross-system equivalences0

No cross-system equivalences mapped for this node.

Report a data issue